Found: 28
Select item for more details and to access through your institution.
Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1166, doi. 10.3390/cancers15041166
- By:
- Publication type:
- Article
Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer.
- Published in:
- World Journal of Urology, 2022, v. 40, n. 9, p. 2195, doi. 10.1007/s00345-022-04077-1
- By:
- Publication type:
- Article
Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness.
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3765, doi. 10.3390/cancers14153765
- By:
- Publication type:
- Article
Gene Expression Monotonicity across Bladder Cancer Stages Informs on the Molecular Pathogenesis and Identifies a Prognostic Eight-Gene Signature.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2542, doi. 10.3390/cancers14102542
- By:
- Publication type:
- Article
A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1995, doi. 10.3390/cancers14081995
- By:
- Publication type:
- Article
Diagnostische Marker in der Urologie.
- Published in:
- Der Urologe A, 2021, v. 60, n. 10, p. 1323, doi. 10.1007/s00120-021-01568-8
- By:
- Publication type:
- Article
Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3786, doi. 10.3390/cancers13153786
- By:
- Publication type:
- Article
A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients' Omics Signatures.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3519, doi. 10.3390/cancers12123519
- By:
- Publication type:
- Article
Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 9, p. 655, doi. 10.3390/diagnostics10090655
- By:
- Publication type:
- Article
Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 9, p. 658, doi. 10.3390/diagnostics10090658
- By:
- Publication type:
- Article
Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma.
- Published in:
- Journal of Biomedical Science, 2020, v. 27, n. 1, p. 1, doi. 10.1186/s12929-019-0599-5
- By:
- Publication type:
- Article
Proteome‐based classification of Nonmuscle Invasive Bladder Cancer.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 1, p. 281, doi. 10.1002/ijc.32556
- By:
- Publication type:
- Article
Author Correction: Urinary CE-MS peptide marker pattern for detection of solid tumors.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Peptidomics and proteomics based on CE‐MS as a robust tool in clinical application: The past, the present, and the future.
- Published in:
- Electrophoresis, 2019, v. 40, n. 18/19, p. 2294, doi. 10.1002/elps.201900091
- By:
- Publication type:
- Article
CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Urinary Glycopeptide Analysis for the Investigation of Novel Biomarkers.
- Published in:
- Proteomics - Clinical Applications, 2019, v. 13, n. 3, p. N.PAG, doi. 10.1002/prca.201800111
- By:
- Publication type:
- Article
Front Cover: Clinical Proteomics on the Path Toward Implementation: First Promises Delivered.
- Published in:
- Proteomics - Clinical Applications, 2019, v. 13, n. 2, p. N.PAG, doi. 10.1002/prca.201970021
- By:
- Publication type:
- Article
Clinical Proteomics on the Path Toward Implementation: First Promises Delivered.
- Published in:
- Proteomics - Clinical Applications, 2019, v. 13, n. 2, p. N.PAG, doi. 10.1002/prca.201800094
- By:
- Publication type:
- Article
Proteomics in Drug Development: The Dawn of a New Era?
- Published in:
- Proteomics - Clinical Applications, 2019, v. 13, n. 2, p. N.PAG, doi. 10.1002/prca.201800087
- By:
- Publication type:
- Article
Proteomics biomarkers for solid tumors: Current status and future prospects.
- Published in:
- Mass Spectrometry Reviews, 2019, v. 38, n. 1, p. 49, doi. 10.1002/mas.21572
- By:
- Publication type:
- Article
Promise and Implementation of Proteomic Prostate Cancer Biomarkers.
- Published in:
- Diagnostics (2075-4418), 2018, v. 8, n. 3, p. 57, doi. 10.3390/diagnostics8030057
- By:
- Publication type:
- Article
Clinical Proteomics: Closing the Gap from Discovery to Implementation.
- Published in:
- Proteomics, 2018, v. 18, n. 14, p. 1, doi. 10.1002/pmic.201700463
- By:
- Publication type:
- Article
Urinary CE-MS peptide marker pattern for detection of solid tumors.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. N.PAG, doi. 10.1038/s41598-018-23585-y
- By:
- Publication type:
- Article
Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.
- Published in:
- Proteomics - Clinical Applications, 2018, v. 12, n. 2, p. 46, doi. 10.1002/prca.201700074
- By:
- Publication type:
- Article
Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findings.
- Published in:
- Scientific Reports, 2016, p. 25619, doi. 10.1038/srep25619
- By:
- Publication type:
- Article
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.
- Published in:
- Clinical & Translational Medicine, 2014, v. 3, n. 1, p. 1, doi. 10.1186/2001-1326-3-7
- By:
- Publication type:
- Article
Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on bladder cancer.
- Published in:
- Proteomics - Clinical Applications, 2013, v. 7, n. 11/12, p. 779, doi. 10.1002/prca.201300038
- By:
- Publication type:
- Article